CD44 and neoplasm: We observed novel tumor-initiating cell-like characteristics in a CD44+CD133+ subpopulation of Caco-2 cells, and showed that treating this subpopulation with XAV939 repressed tumor-initiating properties, including suppression of cell proliferation in culture and tumorigenic potential in mice.